Skip to main content
PlainMeds

What the label lists and what reports show

Chorionic and gonadotropin side effects

Chorionic and gonadotropin's FDA label lists its adverse reactions in its own words. FAERS holds 582 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is ovarian hyperstimulation syndrome (109 reports).

  • No generic listed

Check it at the source: the chorionic and gonadotropin FDA label on DailyMed (effective August 27, 2025); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

(see WARNINGS ) Headache, irritability, restlessness, depression, fatigue, edema, precocious puberty, gynecomastia, pain at the site of injection. Hypersensitivity reactions both localized and systemic in nature, including erythema, urticaria, rash, angioedema, dyspnea and shortness of breath, have been reported. The relationship of these allergic-like events to the polypeptide hormone or the diluent containing benzyl alcohol is not clear.

Source: FDA drug label, Ferring Pharmaceuticals Inc., effective August 27, 2025 (SPL set ac6918ff-9dc3-40d9-8619-54b26e4bdfc8), via openFDA; the full label on DailyMed

What do FAERS reports show?

582 reports list chorionic and gonadotropin among the medicines taken, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 151 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 19 reactions below, 4 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Ovarian Hyperstimulation Syndrome109
  • Drug Ineffective (a use or a product term, not a reaction)56
  • Nausea42
  • Off Label Use (a use or a product term, not a reaction)35
  • Headache (named in the label)30
  • Abdominal Distension27
  • Vomiting26
  • Fatigue (named in the label)25
  • Product Administration Interrupted25
  • Dyspnoea (named in the label)24
  • Product Use In Unapproved Indication (a use or a product term, not a reaction)22
  • Rash (named in the label)17
  • Pain16
  • Product Dose Omission Issue (a use or a product term, not a reaction)16
  • Abdominal Pain15
  • Abortion Spontaneous15
  • Ascites15
  • Maternal Exposure During Pregnancy (a use or a product term, not a reaction)15
  • Surgery15
  • Abdominal Discomfort13
  • Diarrhoea12
  • Dizziness12
  • Maternal Exposure Before Pregnancy (a use or a product term, not a reaction)12
  • Weight Increased12
  • Hypertension11

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Chorionic and gonadotropin: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions